NO981698D0 - Ren 3R-3'R stereoisomer av zeaxanthin til Õ behandle macular degeneration hos mennesker - Google Patents

Ren 3R-3'R stereoisomer av zeaxanthin til Õ behandle macular degeneration hos mennesker

Info

Publication number
NO981698D0
NO981698D0 NO981698A NO981698A NO981698D0 NO 981698 D0 NO981698 D0 NO 981698D0 NO 981698 A NO981698 A NO 981698A NO 981698 A NO981698 A NO 981698A NO 981698 D0 NO981698 D0 NO 981698D0
Authority
NO
Norway
Prior art keywords
zeaxanthin
stereoisomer
humans
pure
macular degeneration
Prior art date
Application number
NO981698A
Other languages
English (en)
Other versions
NO981698L (no
Inventor
Kevin M Garnett
Dennis L Gierhart
Luis H Guerra-Santos
Original Assignee
Applied Food Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/551,153 external-priority patent/US5827652A/en
Priority claimed from US08/551,166 external-priority patent/US5854015A/en
Application filed by Applied Food Biotech Inc filed Critical Applied Food Biotech Inc
Publication of NO981698D0 publication Critical patent/NO981698D0/no
Publication of NO981698L publication Critical patent/NO981698L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO981698A 1995-10-31 1998-04-16 Ren 3R-3'R stereoisomer av zeaxanthin til Õ behandle macular degeneration hos mennesker NO981698L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/551,153 US5827652A (en) 1995-10-31 1995-10-31 Zeaxanthin formulations for human ingestion
US08/551,166 US5854015A (en) 1995-10-31 1995-10-31 Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
PCT/US1996/017563 WO1997016175A1 (en) 1995-10-31 1996-10-30 Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans

Publications (2)

Publication Number Publication Date
NO981698D0 true NO981698D0 (no) 1998-04-16
NO981698L NO981698L (no) 1998-06-08

Family

ID=27069666

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981698A NO981698L (no) 1995-10-31 1998-04-16 Ren 3R-3'R stereoisomer av zeaxanthin til Õ behandle macular degeneration hos mennesker

Country Status (14)

Country Link
JP (1) JPH10512594A (no)
KR (1) KR100570251B1 (no)
CN (1) CN1104235C (no)
AR (1) AR004245A1 (no)
AU (1) AU710634B2 (no)
BR (1) BR9611488A (no)
CZ (1) CZ297575B6 (no)
FI (1) FI980947A (no)
HU (1) HU223208B1 (no)
NO (1) NO981698L (no)
PL (1) PL185465B1 (no)
RU (1) RU2197958C2 (no)
WO (1) WO1997016175A1 (no)
ZA (1) ZA969139B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
GB0501365D0 (en) 2005-01-21 2005-03-02 Promar As Compositions
WO2006086706A2 (en) * 2005-02-11 2006-08-17 Kalamazoo Holdings, Inc. A capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
US8592662B2 (en) 2005-02-11 2013-11-26 Kalamazoo Holdings, Inc. Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US308759A (en) * 1884-12-02 Curling hat-brims and machine therefor
DE69030817T2 (de) * 1989-08-30 1997-10-16 Applied Food Biotech Inc Verfahren zur Herstellung einer Zeaxanthin enthaltenden Zusammensetzung mittels eines Mikroorganismus der Spezies Flavobacterium multivorum
US5310764A (en) * 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene

Also Published As

Publication number Publication date
WO1997016175A1 (en) 1997-05-09
KR100570251B1 (ko) 2006-06-21
CN1201388A (zh) 1998-12-09
HU223208B1 (hu) 2004-03-29
FI980947A0 (fi) 1996-10-30
PL326558A1 (en) 1998-09-28
AU7050196A (en) 1997-05-08
RU2197958C2 (ru) 2003-02-10
KR19990067180A (ko) 1999-08-16
PL185465B1 (pl) 2003-05-30
CZ130998A3 (cs) 1998-07-15
CN1104235C (zh) 2003-04-02
CZ297575B6 (cs) 2007-02-07
JPH10512594A (ja) 1998-12-02
ZA969139B (en) 1997-09-25
NO981698L (no) 1998-06-08
BR9611488A (pt) 1999-01-19
FI980947A (fi) 1998-04-29
AR004245A1 (es) 1998-11-04
HUP9802314A3 (en) 1999-05-28
MX9605248A (es) 1998-06-30
AU710634B2 (en) 1999-09-23
HUP9802314A2 (hu) 1999-04-28

Similar Documents

Publication Publication Date Title
ATE195527T1 (de) Neue steroidester zur behandlung von hauterkrankungen
NO994014L (no) Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
DE59711321D1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
NO952573D0 (no) Blandinger for behandling av diabetiske komplikasjoner
NO972972D0 (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
BR9607808A (pt) Composição para limpeza da pele e processo para realçar o efeito antimicrobiano das formulações para limpeza da pele
DK0725097T3 (da) Anvendelse af humant atrialt natriuretisk peptid til fremstilling af farmaceutiske præparater til behandling af akut lungeb
ATE239498T1 (de) Entzündungshemmende zusammensetzung
PL330862A1 (en) Clinical application of proteinous kinase c in order to increase clinical effectiveness of anticarcinogenic pharmaco- and radiotherapy
NO973243D0 (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av gynekologiske sykdommer
IS5333A (is) Prostaglandínafleiður án hliðarverkana til að meðhöndla gláku
DE69841984D1 (de) Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen
PL327400A1 (en) Application of lyphylised pge-1 containing liposomes in treating erection disorders
ITBO940146A0 (it) Derivati di acidi biliari utili nella terapia della calcolosi biliare da colesterolo e nelle patologie indotte da colestasi
NO981698L (no) Ren 3R-3'R stereoisomer av zeaxanthin til Õ behandle macular degeneration hos mennesker
PT900563E (pt) Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
NO973342D0 (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av cerebrale degenerative sykdommer
ZA969147B (en) Application of the gax protein to the treatment of cancer
HUP9901247A3 (en) Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
ZA971607B (en) Methods of treatment of allergic diseases
ITBO940526A0 (it) Procedimento per ottenere olive colorate
NO973341D0 (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse
FI972637A (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application